Mid Cap and Large Cap Watch List member IMS Health (RX) delivered 14% revenue and 15% operating income growth in the first quarter: IMS Health, the world’s leading provider of market intelligence to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback